Articles with Vaxart, Inc.
avir20170630_10k.htm
Vaxart stock slips more than 8% as Q3 expenses jump, cash position deteriorates | Seeking Alpha
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
COVID-19 Vaccines: Global Health Issues
Novavax - News, Articles etc. - European Pharmaceutical Review
Biomedicines | Free Full-Text | Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
Articles with Vaxart, Inc.
avir20170630_10k.htm
avir20170630_10k.htm
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Vaxart Has Developed the First Oral Investigational COVID-19 Vaccine
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Overview of Different Platforms
COVID-19 tracker: Omicron booster nods expected Wednesday
Conversation with Albert Bourla, CEO of Pfizer | chief executive officer, Pfizer | Conversation with Albert Bourla, CEO of Pfizer A conversation with Pfizer Chief Executive Officer Albert Bourla | By World
Vaxart (VXRT): Great Potential But Issues Remain | Seeking Alpha
Vaxart, Inc. – SEC Filing
Vaxart, Inc. – SEC Filing
